Zhou Shiqiang – Trademark Portfolio

Entity Type: 01

Zhou Shiqiang owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as JOZIT, KAJEE, BOFAYS, and FACOTY. Of these, 4 are registered. The portfolio spans 3 Nice Classification classes, led by Class 25 (Clothing) and Class 24 (Fabrics). Headquartered in Dalian.

No.547,Dalianpao Tun,Dalianpao Village

Qidingshan Manzu Township,Jinzhou Dist

Dalian 116000 , CN

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPULEBOX
OPULEBOX
Abandoned 2024
OPULEBOX
OPULEBOX
Abandoned 2024
JOZIT
JOZIT
Registered 2020
KAJEE
KAJEE
Registered 2020
BOFAYS
BOFAYS
Registered 2020
FACOTY
FACOTY
Registered 2020

Trademark Classifications

Zhou Shiqiang's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (2 filings)

Clothing, footwear, headgear

24
Fabrics (2 filings)

Textiles and textile goods; bed covers; table covers

34
Smokers Articles (2 filings)

Tobacco; smokers articles; matches

Frequently Asked Questions

How many trademarks does Zhou Shiqiang have?

Zhou Shiqiang has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned.

What trademark classes does Zhou Shiqiang file in?

Zhou Shiqiang files trademarks across 3 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 24 (Fabrics), Class 34 (Smokers Articles). Class 25 covers clothing, footwear, headgear.

What are Zhou Shiqiang's most well-known trademarks?

Zhou Shiqiang's registered trademark portfolio includes well-known marks such as JOZIT, KAJEE, BOFAYS, and FACOTY. These are among 4 currently registered trademarks in the portfolio.

What is Zhou Shiqiang's trademark registration success rate?

Zhou Shiqiang has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.